Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2025-12-25 @ 11:19 PM
Study NCT ID:
NCT04115293
Status:
COMPLETED
Last Update Posted:
2025-07-16
First Post:
2019-10-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Sponsor:
Ra Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-02
First Submit QC Date:
None
Study First Post Date:
2019-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-19
Results First Submit QC Date:
None
Results First Post Date:
2023-01-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-04
Last Update Post Date:
2025-07-16
Last Update Post Date Type:
ACTUAL